Dengfeng Wang, Hong Liu, Lihong Chen, Mian He, Weidong Zhao, Yang Xiang, Guoqinq Wang, Guonan Zhang. "A phase II study of anlotinib plus penpulimab as first-line treatment for persistent, recurrent, or metastatic cervical cancer: Results from ALTER-GO-020 trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.5527